Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Cancer Immunol Immunother

Search In Journal Title:

Abbravation: Cancer Immunology, Immunotherapy

Search In Journal Abbravation:

Publisher

Springer Berlin Heidelberg

Search In Publisher:

DOI

10.1007/978-4-431-98074-2_11

Search In DOI:

ISSN

1432-0851

Search In ISSN:
Search In Title Of Papers:

Heterogeneity of CD8Superscript+/Superscript t

Authors: Joseph M Obeid Nolan A Wages Yinin Hu Donna H Deacon Craig L Slingluff
Publish Date: 2016/10/21
Volume: 66, Issue: 1, Pages: 33-43
PDF Link

Abstract

Infiltration of nonsmallcell lung cancer NSCLC by CD8+ T lymphocytes predicts improved patient survival however heterogeneity of intratumoral localization complicates this assessment Strategies for tumor sampling may not accurately represent the whole tumor We hypothesized that sampling strategies may alter the identification of tumors with high CD8 density and affect the prognostic significanceTwentythree primary NSCLC tumors were immunohistochemically stained for CD8 and were assessed using automated software with eight different sampling strategies or the whole tumor Results of all sampling strategies were compared to the whole tumor counts paired t tests Pearson’s r Associations between CD8 densities and overall survival were assessed logrank testCounts from all eight sampling strategies significantly correlated with whole tumor counts p ≤ 0001 However the magnitude of CD8+ cell counts and categorization into high vs low infiltrate groups were affected by the sampling strategy The most concordant values were derived from random sampling of 20  of the tumor a simulated core biopsy or from sampling the tumor center TIL infiltration was associated with survival when sampling the center p = 0038 but not the invasive margin p  02 or other strategiesDifferent tumor sampling strategies may yield discordant TIL density results and different stratification for risk assessment Small biopsies may be particularly unrepresentative Random sampling of larger tumor areas is recommended Enumerating CD8+ T cells in the tumor center may have prognostic value


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy
  2. Second International Symposium on Cancer Biology (ISCB), November 14–16, 2011, at the National Institute of Immunology, New Delhi, India
  3. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients
  4. Saccharomyces cerevisiae , the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice
  5. Higher numbers of T-bet + intratumoral lymphoid cells correlate with better survival in gastric cancer
  6. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E 2 results in high interleukin-12 production and cell migration
  7. Increase in CD14 + HLA-DR −/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
  8. CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells
  9. Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
  10. Epigenetic regulation of immune escape genes in cancer
  11. The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis
  12. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses
  13. Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle
  14. −509C>T polymorphism in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection
  15. Bridging the innate and adaptive immune responses against cancer: 95th AACR meeting 2004
  16. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
  17. Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
  18. Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells
  19. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms
  20. H 2 O 2 production within tumor microenvironment inversely correlated with infiltration of CD56 dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction
  21. Lenalidomide enhances anti-myeloma cellular immunity
  22. Epidemiology: allergy history, IgE, and cancer
  23. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
  24. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
  25. Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
  26. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors
  27. Chordoma and chondrosarcoma gene profile: implications for immunotherapy
  28. Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
  29. Extracellular adenosine metabolism in immune cells in melanoma
  30. Collective action of hematopoietic cell subsets mediates anti-IL10R1 and CpG tumor immunity
  31. Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
  32. Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies
  33. Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function
  34. Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis

Search Result: